Matches in Wikidata for { <http://www.wikidata.org/entity/Q46616119> ?p ?o ?g. }
- Q46616119 description "2008 nî lūn-bûn" @default.
- Q46616119 description "2008年の論文" @default.
- Q46616119 description "2008年学术文章" @default.
- Q46616119 description "2008年学术文章" @default.
- Q46616119 description "2008年学术文章" @default.
- Q46616119 description "2008年学术文章" @default.
- Q46616119 description "2008年学术文章" @default.
- Q46616119 description "2008年学术文章" @default.
- Q46616119 description "2008年學術文章" @default.
- Q46616119 description "2008年學術文章" @default.
- Q46616119 description "2008年學術文章" @default.
- Q46616119 description "2008年學術文章" @default.
- Q46616119 description "2008年學術文章" @default.
- Q46616119 description "2008년 논문" @default.
- Q46616119 description "article científic" @default.
- Q46616119 description "article scientific" @default.
- Q46616119 description "article scientifique" @default.
- Q46616119 description "articol științific" @default.
- Q46616119 description "articolo scientifico" @default.
- Q46616119 description "artigo científico" @default.
- Q46616119 description "artigo científico" @default.
- Q46616119 description "artigo científico" @default.
- Q46616119 description "artikel ilmiah" @default.
- Q46616119 description "artikull shkencor" @default.
- Q46616119 description "artikulong pang-agham" @default.
- Q46616119 description "artykuł naukowy" @default.
- Q46616119 description "artículo científico publicado en 2008" @default.
- Q46616119 description "artículu científicu" @default.
- Q46616119 description "bilimsel makale" @default.
- Q46616119 description "bài báo khoa học" @default.
- Q46616119 description "naučni članak" @default.
- Q46616119 description "scienca artikolo" @default.
- Q46616119 description "scientific article published in May 2008" @default.
- Q46616119 description "scientific article published in May 2008" @default.
- Q46616119 description "scientific article published in May 2008" @default.
- Q46616119 description "teaduslik artikkel" @default.
- Q46616119 description "tieteellinen artikkeli" @default.
- Q46616119 description "tudományos cikk" @default.
- Q46616119 description "vedecký článok" @default.
- Q46616119 description "vetenskaplig artikel" @default.
- Q46616119 description "videnskabelig artikel" @default.
- Q46616119 description "vitenskapelig artikkel" @default.
- Q46616119 description "vitskapeleg artikkel" @default.
- Q46616119 description "vědecký článek" @default.
- Q46616119 description "wetenschappelijk artikel" @default.
- Q46616119 description "wissenschaftlicher Artikel" @default.
- Q46616119 description "επιστημονικό άρθρο" @default.
- Q46616119 description "мақолаи илмӣ" @default.
- Q46616119 description "наукова стаття, опублікована в травні 2008" @default.
- Q46616119 description "научна статия" @default.
- Q46616119 description "научная статья" @default.
- Q46616119 description "научни чланак" @default.
- Q46616119 description "научни чланак" @default.
- Q46616119 description "מאמר מדעי" @default.
- Q46616119 description "مقالة علمية نشرت في مايو 2008" @default.
- Q46616119 description "মে ২০০৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q46616119 description "บทความทางวิทยาศาสตร์" @default.
- Q46616119 description "სამეცნიერო სტატია" @default.
- Q46616119 name "Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases" @default.
- Q46616119 name "Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases" @default.
- Q46616119 type Item @default.
- Q46616119 label "Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases" @default.
- Q46616119 label "Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases" @default.
- Q46616119 prefLabel "Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases" @default.
- Q46616119 prefLabel "Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases" @default.
- Q46616119 P1433 Q46616119-8CE718AB-1105-4797-BFD7-9AA328DE5CB2 @default.
- Q46616119 P1476 Q46616119-92798E25-EA84-4728-92AB-F66C57429A96 @default.
- Q46616119 P2093 Q46616119-04B7AAA2-BA39-4B3C-A861-B4FE94F7B09E @default.
- Q46616119 P2093 Q46616119-14CD5C21-BB64-44AC-9991-84062292D858 @default.
- Q46616119 P2093 Q46616119-2667E51A-E17D-4AC0-98AE-E3AFF8B7DA3D @default.
- Q46616119 P2093 Q46616119-7B8F28FE-D3FA-46EF-BEEA-64ED0A78BE03 @default.
- Q46616119 P2093 Q46616119-86D46EFA-0506-4CD7-8B77-9C902F6468D4 @default.
- Q46616119 P2093 Q46616119-A0E55306-6DE8-4AD9-A1C5-3F98DF91BBFF @default.
- Q46616119 P2093 Q46616119-B57886FB-A5DD-4981-B61A-5FDD01B3B9B4 @default.
- Q46616119 P2093 Q46616119-B6955AA2-9C7C-43C7-BB30-ED1456E469E0 @default.
- Q46616119 P2093 Q46616119-B72E58C4-F7F5-41C4-A4C9-A87CC95C4DD0 @default.
- Q46616119 P2093 Q46616119-C053576E-1A46-4748-A62A-436885325389 @default.
- Q46616119 P2093 Q46616119-C4037994-6D35-4808-AAC5-29492813567E @default.
- Q46616119 P2093 Q46616119-C9A32A50-32C5-4F73-B75A-A8D930C7F934 @default.
- Q46616119 P2093 Q46616119-DBCF1E6C-1CF2-4EDC-A410-9D9703781119 @default.
- Q46616119 P2093 Q46616119-E2C9E4CB-BCAD-4055-B3FD-9388E9700837 @default.
- Q46616119 P2093 Q46616119-EA47229B-BD02-4C97-AFD9-32DA42D77F76 @default.
- Q46616119 P304 Q46616119-9B38AF9E-F2B5-4C73-BF90-B5A7CA43A3F6 @default.
- Q46616119 P31 Q46616119-3590CF8E-CDD6-4A41-95DB-E9B72856EB3C @default.
- Q46616119 P356 Q46616119-90F03F4E-D2A9-44F0-8D69-7DDEE41E72AE @default.
- Q46616119 P407 Q46616119-F6630ED5-DC69-467E-9331-0530CE5B46D7 @default.
- Q46616119 P433 Q46616119-B4E58C89-641E-4889-992E-ABC63D82F1A1 @default.
- Q46616119 P478 Q46616119-86C21AE2-F363-4FCA-BF3F-FB9FAFE8EBD1 @default.
- Q46616119 P50 Q46616119-26D1FD59-7B2F-4F55-9AF8-25A0F3B507DE @default.
- Q46616119 P50 Q46616119-3E342DD9-69B4-479F-BD00-5FA4A0867983 @default.
- Q46616119 P50 Q46616119-C4507400-97D9-4886-BC37-DC5FE943485B @default.
- Q46616119 P50 Q46616119-FB2282D7-FE26-4888-B10C-ABD810ED43CC @default.
- Q46616119 P577 Q46616119-2117633A-137E-4115-A061-F6C18AA23CEE @default.
- Q46616119 P698 Q46616119-69D95ACC-ACEA-492D-BCF2-D34013ADF3C0 @default.
- Q46616119 P921 Q46616119-870993F4-7EF3-492F-9431-62E1A6528973 @default.
- Q46616119 P356 1078-0432.CCR-07-4575 @default.
- Q46616119 P698 18451237 @default.
- Q46616119 P1433 Q332253 @default.
- Q46616119 P1476 "Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases" @default.
- Q46616119 P2093 "Ajia Town" @default.